Paper50159
The analgesic properties of delta-9-tetrahydrocannabinol and codeine.
Noyes R and 3 others. Clin Pharmacol Ther, 1975. Cited by 264 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Papers, record 50159. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/50159
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Cannabis | Major topic |
| Codeine | Major topic |
| Dronabinol | Major topic |
| Pain | Major topic |
| Palliative Care | Major topic |
| Phytotherapy | Major topic |
| Aspirin | |
| Clinical Trials as Topic | |
| Dextropropoxyphene | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasms | |
| Placebos |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,312,243 | Association Between Cannabis Use and Tinnitus: A Multi-Center Propensity-Score-Matched Cohort Study. | OTO Open | 2026 | https://conductscience.org/library/papers/42312243 | PubMed |
| 41,751,466 | In Silico Molecular Docking and Pharmacokinetic Evaluation of Cannabinoid Derivatives as Multi-Target Inhibitors for EGFR, VEGFR-1, and VEGFR-2 Proteins. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751466 | PubMed |
| 39,739,175 | The Role of Cannabinoids and the Endocannabinoid System in the Treatment and Regulation of Nausea and Vomiting. | Curr Top Behav Neurosci | 2026 | https://conductscience.org/library/papers/39739175 | PubMed |
| 39,694,905 | Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review. | Support Care Cancer | 2024 | https://conductscience.org/library/papers/39694905 | PubMed |
| 39,629,058 | Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. | Clin Ophthalmol | 2024 | https://conductscience.org/library/papers/39629058 | PubMed |
| 39,596,719 | Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39596719 | PubMed |
| 39,110,350 | The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine. | Curr Oncol Rep | 2024 | https://conductscience.org/library/papers/39110350 | PubMed |
| 38,079,061 | Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer - An Overview. | Curr Treat Options Oncol | 2023 | https://conductscience.org/library/papers/38079061 | PubMed |
| 37,521,486 | Should oncologists trust cannabinoids? | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37521486 | PubMed |
| 37,515,745 | The Exploration of Cannabis and Cannabinoid Therapies for Migraine. | Curr Pain Headache Rep | 2023 | https://conductscience.org/library/papers/37515745 | PubMed |
| 37,283,486 | Cannabis-based medicines and medical cannabis for adults with cancer pain. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37283486 | PubMed |
| 36,897,501 | Medical Cannabis for Chronic Nonmalignant Pain Management. | Curr Pain Headache Rep | 2023 | https://conductscience.org/library/papers/36897501 | PubMed |
| 36,872,397 | MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events. | Support Care Cancer | 2023 | https://conductscience.org/library/papers/36872397 | PubMed |
| 36,823,672 | Cannabis use amongst tinnitus patients: consumption patterns and attitudes. | J Otolaryngol Head Neck Surg | 2023 | https://conductscience.org/library/papers/36823672 | PubMed |
| 36,639,601 | Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks. | Pain Ther | 2023 | https://conductscience.org/library/papers/36639601 | PubMed |
| 36,467,783 | Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We? | Med Cannabis Cannabinoids | 2022 | https://conductscience.org/library/papers/36467783 | PubMed |
| 36,291,926 | Use of Cannabis and Cannabinoids for Treatment of Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291926 | PubMed |
| 36,078,963 | Practical Considerations for the Use of Cannabis in Cancer Pain Management-What a Medical Oncologist Should Know. | J Clin Med | 2022 | https://conductscience.org/library/papers/36078963 | PubMed |
| 35,982,439 | Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. | BMC Med | 2022 | https://conductscience.org/library/papers/35982439 | PubMed |
| 35,779,108 | Cannabinoid consumption among cancer patients receiving systemic anti-cancer treatment in the Netherlands. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35779108 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/50159
GET https://conductscience.org/api/papers/v1/50159/cited_by?page=2